MSF Access Campaign
As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination
Time for $5: MSF demands Cepheid and Danaher lower the price of medical tests
MSF response to signing of EFTA-India trade agreement
MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease
MSF: TB test price reduction by Cepheid and Danaher is an important step in the right direction
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
Transforming lives in Mozambique: surgical treatment for patients with neglected diseases in Mogovolas district
Gavi must do more as WHO/UNICEF estimates show slow childhood vaccination recovery
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
